Limited Partnership Sanderling VI, 10% Owner at Pacira Pharmaceuticals, Inc. (PCRX), bought 221,478 shares at $7.00 ($1.6M) on 2011-02-08, disclosed to the SEC on 2011-02-10.
Open-market purchase of $1.6M PCRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 4,297 | $30K | 1.9% |
| 2 | $7.00 | 5,119 | $36K | 2.3% |
| 3 | $7.00 | 27,931 | $196K | 12.6% |
| 4 | $7.00 | 184,131 | $1.3M | 83.1% |
| Total | $7.00 avg | 221,478 | $1.6M | 100% |